The Committee holds a hearing entitled, "Drug Pricing in America: A Prescription for Change--Part 1I" with Richard Gonzalez, CEO of AbbVie, Pascal Soriot, CEO of AstraZeneca, Giovanni Caforio, CEO of Bristol-Myers Squibb; Jennifer Taubert, EVP of Janssen Pharmaceuticals (Johnson & Johnson), Albert Bourla, CEO of Pfizer, Olivier Brandicourt, CEO of Sanofi and Kenneth Frazier, CEO of Merck on February 26 at 10:15 am. Webcast Link